Compounds > chloroquine

chloroquine and pafuramidine

chloroquine has been researched along with pafuramidine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bakunov, SA; Bakunova, SM; Brun, R; Ghebru, M; Tidwell, RR; Wenzler, T; Werbovetz, KA1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Andrews, KT; Bouchut, A; Chua, MJ; Erdmann, F; Khalife, J; Pierrot, C; Robaa, D; Sauer, B; Schmidt, M; Sippl, W; Skinner-Adams, TS1
Meshnick, SR; Purfield, AE; Tidwell, RR1

Reviews

1 review(s) available for chloroquine and pafuramidine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

4 other study(ies) available for chloroquine and pafuramidine

ArticleYear
Synthesis and antiprotozoal activity of cationic 1,4-diphenyl-1H-1,2,3-triazoles.
    Journal of medicinal chemistry, 2010, Jan-14, Volume: 53, Issue:1

    Topics: Amidines; Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Disease Models, Animal; Female; Leishmania donovani; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Rats; Stereoisomerism; Structure-Activity Relationship; Triazoles; Trypanosoma brucei rhodesiense

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Synthesis, biological characterisation and structure activity relationships of aromatic bisamidines active against Plasmodium falciparum.
    European journal of medicinal chemistry, 2017, Feb-15, Volume: 127

    Topics: Antimalarials; Caco-2 Cells; Chemistry Techniques, Synthetic; Drug Design; Furans; HEK293 Cells; Humans; Plasmodium falciparum; Structure-Activity Relationship

2017
Interactions of DB75, a novel antimalarial agent, with other antimalarial drugs in vitro.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6

    Topics: Animals; Antimalarials; Atovaquone; Benzamidines; Chloroquine; Drug Interactions; Parasitic Sensitivity Tests; Plasmodium falciparum

2008